Response-Based Therapy Assessed By PET Scan in Treating Patients With Bulky Stage I and Stage II Classical Hodgkin Lymphoma



Status:Active, not recruiting
Conditions:Lymphoma
Therapuetic Areas:Oncology
Healthy:No
Age Range:18 - 60
Updated:1/26/2019
Start Date:September 2010

Use our guide to learn which trials are right for you!

Phase II Trial of Response-Adapted Therapy Based on Positron Emission Tomography (PET) for Bulky Stage I and Stage II Classical Hodgkin Lymphoma (HL)

This research is being done in order to improve treatment outcomes in patients diagnosed with
bulky, early stage Hodgkin lymphoma and to reduce the side effects that are associated with
use of radiation used in current treatments. The chemotherapy treatment in this study
consists of a combination of four drugs approved by the Food and Drug Administration (FDA):
doxorubicin, bleomycin, vinblastine, and dacarbazine. This regimen (called ABVD) has been
found to be effective in treating patients with Hodgkin lymphoma and is considered the
standard of treatment used with radiation therapy in patients with bulky early stage Hodgkin
lymphoma. As part of the evaluation of the effectiveness of the chemotherapy treatment, PET
scans will be obtained during the course of therapy. The usefulness of this PET scan will be
evaluated to determine whether radiation may be left out in the treatment of disease if the
PET scan shows that the patient has responded to chemotherapy alone. The plan is to identify
a group of patients using early PET scans in order to change to a chemotherapy treatment
called BEACOPP (bleomycin, etoposide, doxorubicin, cyclophosphamide, vincristine,
procarbazine and prednisone). It is one of the most highly effective chemotherapy regimens
for Hodgkin lymphoma, but is associated with more side effects than ABVD. Although it has
become standard of care in Europe, its use has been more limited in the U.S. because of
concerns about toxicity.

This is single-arm phase II clinical trial of response-adapted therapy based on PET for bulky
stage I and stage II Hodgkin lymphoma. A maximum of 123 patients will be entered to the
study. The primary outcome of this study is progression-free survival (PFS), defined as the
time from study entry to disease progression or death.

Primary Objective:

To determine the progression-free survival (PFS) at 36 months from enrollment for patients
with bulky stage I and II Hodgkin lymphoma. All patients will begin treatment with ABVD.
Patients who are PET negative after 2 cycles of chemotherapy will receive 6 cycles of ABVD
without radiotherapy. Patients who are PET positive after 2 cycles of ABVD will then receive
4 cycles of escalated BEACOPP followed by IFRT. A comparison will be made of the 36-month PFS
between patients who are PET positive and those who are PET negative following 2 cycles of
ABVD.

Secondary Objectives:

1. To evaluate the complete response (CR) rate of patients diagnosed with bulky stage I and
II Hodgkin lymphoma following PET response-adapted chemotherapy with or without
radiation therapy.

2. To determine the predictive value of FDG uptake using various semiquantitative
approaches, at baseline, after 2 cycles of ABVD and at completion of therapy.

3. To determine the predictive value of volumetric vs. 2 dimensional (2-D) measurement
changes on CT between baseline and after 2 cycles, at the end of chemotherapy (PET
negative patients only) and after RT (PET positive patients only) and compare with PET
parameters.

4. To determine if changes in both qualitative and semiquantitative FDG-PET findings
between baseline and after cycle 2, at end of chemotherapy (PET negative patients only)
and after RT (PET positive patients only) with combination analyses with incorporating
changes obtained from dedicated CT scans, correlate with response and PFS.

5. To compare the predictive value of both qualitative and semiquantitative FDG-PET
changes, 2-D and volumetric CT changes, and combinatorial analyses (PET+dedicated CT
data) with molecular parameters, and conventional parameters, including IPS.

6. To assess whether elevated baseline serum soluble CD30 (sCD30), IL10, CCL17, and CCL22
correlate with clinical response and PFS.

7. To assess whether persistent or recurrent elevation of serial serum sCD30, IL10, CCL17,
or CCL22 correlate with relapse/progression or PET scan results.

8. To confirm independently useful tissue biomarkers (bcl-2, MAL, FOXP3, CD68, GzB) for
risk stratification in patients with bulky stage I and II Hodgkin lymphoma treated with
this regimen.

9. To compare mediastinal bulk on standing PA and lateral chest x-ray (> 0.33 maximum chest
diameter) with chest CT (mass > 10 cm).

After completion of study treatment, patients are followed up every 3 months for 1 year,
every 6 months for 2-3 years, and then once a year for a maximum of ten years from the time
of entry on the study.

1. Documentation of Disease:

- Histologically documented Hodgkin lymphoma subclassified according to the WHO
modification of the Rye Classification and staged according to the modified Ann
Arbor Staging Classification system.

- Patients must have clinical stage IA, IB, IIA or IIB.

- Patients with "E" extensions will be eligible if all other criteria have
been met.

- Nodular lymphocyte predominant Hodgkin lymphoma is excluded.

- Core needle biopsies are acceptable if they contain adequate tissue for
primary diagnosis and immunophenotyping. Fine needle aspirates are not
acceptable. If multiple specimens are available, please submit the most
recent. Failure to submit pathology materials within 60 days of patient
registration will be considered a major protocol violation.

- Patients must have a mediastinal mass > 0.33 maximum intrathoracic diameter on
standing postero-anterior chest x-ray or mass measuring > 10 cm in its largest
diameter.

2. Second Malignancy: No "currently active" second malignancy other than non-melanoma
skin cancers. Patients are not considered to have a "currently active" malignancy if
they have completed therapy and are considered by their physician to be at less than
30% risk of relapse.

3. Prior Therapy - Patients may have had one cycle only of ABVD prior to enrolling on
study. No other prior treatment (chemotherapy or radiation therapy) for Hodgkin
lymphoma is allowed. If patient has had one cycle of ABVD, in order to be eligible to
enroll on CALGB 50801, the patient must have had all of the following tests prior to
starting the first cycle of ABVD:

- LVEF by ECHO or MUGA

- PFTs (including DLCO/FVC)CT scan (neck*, chest, abdomen, pelvis)

- FDG-PET/CT scan

- Chest X-ray, PA & Lateral

- CBC, differential, platelets

- ESR

- Serum creatinine

- Glucose

- AST

- Alkaline phosphatase

- Bilirubin

- LDH

Patients with a negative FDG-PET/CT scan do not need to have had a dedicated neck CT
scan prior to starting the previous cycle of ABVD.

4. ECOG Performance status 0-2.

5. LVEF and DLCO - LVEF by ECHO or MUGA within institutional normal limits unless thought
to be disease related. DLCO ≥ 60% with no symptomatic pulmonary disease unless thought
to be disease related.

6. HIV Infection - Patients with known HIV must have a CD4 count > 350 and be on
concurrent antiretrovirals. Patients with a history of intravenous drug abuse or any
behavior associated with an increased risk of HIV infection should be tested for
exposure to the HIV virus. An HIV test is not required for entry on this protocol, but
is required if the patient is perceived to be at risk.

7. Pregnancy Restrictions - Non-pregnant and non-nursing. Due to the teratogenic
potential of the agents used in this study, pregnant or nursing women may not be
enrolled. Women and men of reproductive potential should agree to use an effective
means of birth control.

8. Age Restricitions - Age 18 - 60 years

9. Initial Required Laboratory Data:

- ANC ≥ 1000/μL

- Platelet count ≥ 100,000/μL

- Serum Creatinine ≤ 2 mg/dL

- Bilirubin* ≤ 2 x upper limit of normal

- AST ≤ 2 x upper limit of normal* - In the absence of Gilbert's disease
We found this trial at
55
sites
1 South Prospect Street
Burlington, Vermont 05401
802-656-8990
Principal Investigator: Julian R. Sprague
Phone: 802-656-4101
?
mi
from
Burlington, VT
Click here to add this to my saved trials
401 College Street
Richmond, Virginia 23298
(804) 828-0450
Principal Investigator: Beata Holkova
Phone: 804-628-1939
Virginia Commonwealth University Massey Cancer Center Founded in 1974, VCU Massey Cancer Center is a...
?
mi
from
Richmond, VA
Click here to add this to my saved trials
34800 Bob Wilson Dr,
San Diego, California 92134
(619) 532-6400
Principal Investigator: Craig D. Norris
Phone: 619-532-8712
Naval Medical Center - San Diego We are the largest and most comprehensive military healthcare...
?
mi
from
San Diego, CA
Click here to add this to my saved trials
22 South Greene Street
Baltimore, Maryland 21201
410-328-7904
University of Maryland Greenebaum Cancer Center The University of Maryland Marlene and Stewart Greenebaum Cancer...
?
mi
from
Baltimore, MD
Click here to add this to my saved trials
?
mi
from
Berlin, VT
Click here to add this to my saved trials
450 Brookline Ave
Boston, Massachusetts 2215
617-632-3000
Principal Investigator: Ann S. LaCasce
Phone: 877-442-3324
Dana-Farber Cancer Institute Since it’s founding in 1947, Dana-Farber has been committed to providing adults...
?
mi
from
Boston, MA
Click here to add this to my saved trials
55 Fruit St
Boston, Massachusetts 02114
(617) 724-4000
Principal Investigator: Ann S. LaCasce
Phone: 877-442-3324
Massachusetts General Hospital Cancer Center An integral part of one of the world
?
mi
from
Boston, MA
Click here to add this to my saved trials
?
mi
from
Camden, NJ
Click here to add this to my saved trials
Charlotte, North Carolina 28204
Principal Investigator: David W. Miller
Phone: 704-355-2884
?
mi
from
Charlotte, NC
Click here to add this to my saved trials
Charlotte, North Carolina 28204
Principal Investigator: Nasfat Shehadeh
Phone: 704-384-5369
?
mi
from
Charlotte, NC
Click here to add this to my saved trials
5841 S Maryland Ave
Chicago, Illinois 60637
1-773-702-6180
Phone: 773-702-9574
University of Chicago Comprehensive Cancer Center The University of Chicago Comprehensive Cancer Center (UCCCC) is...
?
mi
from
Chicago, IL
Click here to add this to my saved trials
Chicago, Illinois 60640
?
mi
from
Chicago, IL
Click here to add this to my saved trials
Columbus, Ohio 43210
Principal Investigator: Kristie A. Blum
Phone: 800-293-5066
?
mi
from
Columbus, OH
Click here to add this to my saved trials
Concord, North Carolina 28025
Principal Investigator: David W. Miller
Phone: 704-355-2884
?
mi
from
Concord, NC
Click here to add this to my saved trials
100 North Academy Avenue
Danville, Pennsylvania 17822
570-271-6211
Principal Investigator: Edward J. Gorak
Phone: 904-202-7051
Geisinger Medical Center Since 1915, Geisinger Medical Center has been known as the region’s resource...
?
mi
from
Danville, PA
Click here to add this to my saved trials
2301 Erwin Rd
Durham, North Carolina 27710
919-684-8111
Principal Investigator: Jeffrey Crawford
Phone: 888-275-3853
Duke Univ Med Ctr As a world-class academic and health care system, Duke Medicine strives...
?
mi
from
Durham, NC
Click here to add this to my saved trials
Elkton, Maryland 21921
?
mi
from
Elkton, MD
Click here to add this to my saved trials
Evanston, Illinois 60201
Principal Investigator: David L. Grinblatt
Phone: 847-570-2109
?
mi
from
Evanston, IL
Click here to add this to my saved trials
2700 Wayne Memorial Dr
Goldsboro, North Carolina 27534
(919) 736-1110
Principal Investigator: James N. Atkins
Phone: 919-580-0000
Wayne Memorial Hospital Wayne Memorial Hospital, an affiliate of Wayne Health Corporation, is home to...
?
mi
from
Goldsboro, NC
Click here to add this to my saved trials
Greenville, South Carolina 29607
Principal Investigator: Robert D. Siegel
Phone: 864-255-1713
?
mi
from
Greenville, SC
Click here to add this to my saved trials
1 St. Francis Drive
Greenville, South Carolina 29601
864-255-1000
Principal Investigator: Robert D. Siegel
Phone: 864-255-1713
Saint Francis Hospital This 245-bed, all-private-room facility is located near downtown Greenville, South Carolina. Formerly...
?
mi
from
Greenville, SC
Click here to add this to my saved trials
La Crosse, Wisconsin
Principal Investigator: Kurt Oettel
Phone: 608-775-2385
?
mi
from
La Crosse, WI
Click here to add this to my saved trials
1 Medical Center Dr
Lebanon, New Hampshire 03756
 (603) 650-5000
Principal Investigator: Elizabeth M. Bengtson
Phone: 800-639-6918
Dartmouth Hitchcock Medical Center Dartmouth-Hitchcock is a national leader in patient-centered health care and building...
?
mi
from
Lebanon, NH
Click here to add this to my saved trials
424 Savannah Rd
Lewes, Delaware 19958
(302) 645-3300
Beebe Medical Center Located in beautiful historic Lewes, Delaware, near Rehoboth Beach, Beebe Healthcare offers...
?
mi
from
Lewes, DE
Click here to add this to my saved trials
Lewisburg, Pennsylvania 17837
Principal Investigator: Joseph J. Vadakara
Phone: 570-271-5251
?
mi
from
Lewisburg, PA
Click here to add this to my saved trials
1575 Beam Ave
Maplewood, Minnesota 55109
(651) 232-7000
Principal Investigator: Daniel M. Anderson
Phone: 952-993-1517
Saint John's Hospital - Healtheast St. John's Hospital is committed to providing superior health care...
?
mi
from
Maplewood, MN
Click here to add this to my saved trials
5805 Monclova Rd
Maumee, Ohio 43537
419-794-7720
Principal Investigator: Rex B. Mowat
Phone: 800-444-3561
Toledo Clinic Cancer Centers-Maumee Our doctors evaluate and make recommendations regarding cancer treatment for newly...
?
mi
from
Maumee, OH
Click here to add this to my saved trials
Mishawaka, Indiana 46544
Principal Investigator: Thomas J. Reid
Phone: 800-284-7370
?
mi
from
Mishawaka, IN
Click here to add this to my saved trials
Nashua, New Hampshire 03063
Principal Investigator: Elizabeth M. Bengtson
Phone: 800-639-6918
?
mi
from
Nashua, NH
Click here to add this to my saved trials
445 E 69th St
New York, New York 10021
(212) 746-1067
Principal Investigator: Jia Ruan
Phone: 212-746-1848
Weill Medical College of Cornell University Founded in 1898, and affiliated with what is now...
?
mi
from
New York, NY
Click here to add this to my saved trials
4755 Ogletown-Stanton Road
Newark, Delaware 19718
302-733-1000
Principal Investigator: Gregory A. Masters
Phone: 302-733-6227
Christiana Care Health System - Christiana Hospital A 913-bed, 1.3-million-square-foot, modern facility in Newark, Delaware,...
?
mi
from
Newark, DE
Click here to add this to my saved trials
Newark, Delaware 19713
Principal Investigator: Gregory A. Masters
Phone: 302-733-6227
?
mi
from
Newark, DE
Click here to add this to my saved trials
940 NE 13th St
Oklahoma City, Oklahoma 73190
(405) 271-6458
Principal Investigator: Adam S. Asch
Phone: 405-271-8777
University of Oklahoma Health Sciences Center The OU Health Sciences Center is composed of seven...
?
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
Emile St
Omaha, Nebraska 68198
(402) 559-4000
Phone: 402-559-5520
Univ of Nebraska Med Ctr A vital enterprise in the nation’s heartland, the University of...
?
mi
from
Omaha, NE
Click here to add this to my saved trials
2600 Navarre Ave
Oregon, Ohio 43616
(419) 696-7200
Principal Investigator: Rex B. Mowat
Phone: 800-444-3561
Saint Charles Hospital Since 1953, Mercy St. Charles Hospital has been providing for the healthcare...
?
mi
from
Oregon, OH
Click here to add this to my saved trials
10 Woodland Rd
Saint Helena, California 94574
(707) 963-3611
Principal Investigator: Gregory B. Smith
Phone: 707-967-3698
Saint Helena Hospital Located in the beautiful Napa Valley, St. Helena Hospital remains committed to...
?
mi
from
Saint Helena, CA
Click here to add this to my saved trials
660 S Euclid Ave
Saint Louis, Missouri 63110
(314) 362-5000
Principal Investigator: Nancy L. Bartlett
Phone: 800-600-3606
Washington University School of Medicine Washington University Physicians is the clinical practice of the School...
?
mi
from
Saint Louis, MO
Click here to add this to my saved trials
3850 Park Nicollet Blvd
Saint Louis Park, Minnesota 55416
(952) 993-3123
Principal Investigator: Daniel M. Anderson
Phone: 952-993-1517
Park Nicollet Clinic - Saint Louis Park Park Nicollet Health Services is a nonprofit, integrated...
?
mi
from
Saint Louis Park, MN
Click here to add this to my saved trials
640 Jackson Street
Saint Paul, Minnesota 55101
651-254-3456
Principal Investigator: Daniel M. Anderson
Phone: 952-993-1517
Regions Hospital Established in 1872, Regions Hospital is a private, not-for-profit organization. The hospital provides...
?
mi
from
Saint Paul, MN
Click here to add this to my saved trials
1455 St Francis Ave
Shakopee, Minnesota 55379
(952) 428-3000
Saint Francis Regional Medical Center St. Francis Regional Medical Center has a rich tradition of...
?
mi
from
Shakopee, MN
Click here to add this to my saved trials
615 N Michigan St
South Bend, Indiana 46601
(574) 647-1000
Principal Investigator: Thomas J. Reid
Phone: 800-284-7370
Memorial Hospital of South Bend Memorial Hospital of South Bend is a community-owned, not-for-profit corporation...
?
mi
from
South Bend, IN
Click here to add this to my saved trials
Spartanburg, South Carolina 29303
Principal Investigator: Asim R. Pati
Phone: 800-486-5941
?
mi
from
Spartanburg, SC
Click here to add this to my saved trials
1235 E Cherokee St
Springfield, Missouri 65804
(417) 820-2000
Principal Investigator: Jay W. Carlson
Phone: 800-821-7532
Mercy Hospital Springfield We're continuing a tradition of healing more than 120 years old. Mercy...
?
mi
from
Springfield, MO
Click here to add this to my saved trials
3801 South National Avenue
Springfield, Missouri 65807
(417) 269-6000
Principal Investigator: Jay W. Carlson
Phone: 800-821-7532
CoxHealth South Hospital U.S. News & World Report has ranked CoxHealth one of Missouri's best...
?
mi
from
Springfield, MO
Click here to add this to my saved trials
557 Brookdale Dr
Statesville, North Carolina 28677
(704) 873-5661
Phone: 704-873-2219
Iredell Memorial Hospital Welcome to Iredell Health System, where you'll receive quality healthcare with personal...
?
mi
from
Statesville, NC
Click here to add this to my saved trials
101 Nicolls Rd
Stony Brook, New York 11794
(631) 444-4000
Principal Investigator: Fengshuo Lan
Phone: 800-862-2215
Stony Brook University Medical Center Stony Brook Medicine expresses our shared mission of research, clinical...
?
mi
from
Stony Brook, NY
Click here to add this to my saved trials
5200 Harroun Rd
Sylvania, Ohio 43560
(419) 824-1444
Flower Hospital ProMedica's Mission is to improve your health and well-being. And ProMedica Flower Hospital...
?
mi
from
Sylvania, OH
Click here to add this to my saved trials
Syracuse, New York 13214
Phone: 315-464-4354
?
mi
from
Syracuse, NY
Click here to add this to my saved trials
Toledo, Ohio 43623
Principal Investigator: Rex B. Mowat
Phone: 800-444-3561
?
mi
from
Toledo, OH
Click here to add this to my saved trials
4126 N. Holland Sylvania Road, Suite 105
Toledo, Ohio 43623
419-479-5605
Principal Investigator: Rex B. Mowat
Phone: 800-444-3561
Toledo Clinic Cancer Centers-Toledo Our doctors evaluate and make recommendations regarding cancer treatment for newly...
?
mi
from
Toledo, OH
Click here to add this to my saved trials
Washington, District of Columbia 20007
?
mi
from
Washington,
Click here to add this to my saved trials
929 N St Francis St
Wichita, Kansas 67214
(316) 268-5775
Principal Investigator: Shaker R. Dakhil
Phone: 316-268-5374
Via Christi Regional Medical Center Via Christi Health's rich history of serving the people of...
?
mi
from
Wichita, KS
Click here to add this to my saved trials
Wichita, Kansas 67214
Principal Investigator: Shaker R. Dakhil
Phone: 316-268-5374
?
mi
from
Wichita, KS
Click here to add this to my saved trials
Wilkes-Barre, Pennsylvania 18711
Principal Investigator: Edward J. Gorak
Phone: 904-202-7051
?
mi
from
Wilkes-Barre, PA
Click here to add this to my saved trials
1 Medical Center Blvd
Winston-Salem, North Carolina 27157
336-716-2011
Phone: 336-716-2088
Wake Forest University Health Sciences Welcome to Wake Forest Baptist Medical Center, a fully integrated...
?
mi
from
Winston-Salem, NC
Click here to add this to my saved trials